These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14745351)

  • 21. [Genes & cancer. Card no. 28: PTEN (MMAC, TEP-1) (phosphatase and tensin homolog deleted on chromosome 10)].
    Soussi T
    Bull Cancer; 1999 Sep; 86(9):715-6. PubMed ID: 10576807
    [No Abstract]   [Full Text] [Related]  

  • 22. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis.
    Kim MJ; Cardiff RD; Desai N; Banach-Petrosky WA; Parsons R; Shen MM; Abate-Shen C
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2884-9. PubMed ID: 11854455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
    Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
    Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of human tissue to assess the oncogenic activity of melanoma-associated mutations.
    Chudnovsky Y; Adams AE; Robbins PB; Lin Q; Khavari PA
    Nat Genet; 2005 Jul; 37(7):745-9. PubMed ID: 15951821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.
    Stambolic V; Tsao MS; Macpherson D; Suzuki A; Chapman WB; Mak TW
    Cancer Res; 2000 Jul; 60(13):3605-11. PubMed ID: 10910075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.
    Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K
    Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of PTEN promotes tumor development in malignant melanoma.
    Stahl JM; Cheung M; Sharma A; Trivedi NR; Shanmugam S; Robertson GP
    Cancer Res; 2003 Jun; 63(11):2881-90. PubMed ID: 12782594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.
    She QB; Solit DB; Ye Q; O'Reilly KE; Lobo J; Rosen N
    Cancer Cell; 2005 Oct; 8(4):287-97. PubMed ID: 16226704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cells. PTEN--coupling tumor suppression to stem cells?
    Penninger JM; Woodgett J
    Science; 2001 Dec; 294(5549):2116-8. PubMed ID: 11739945
    [No Abstract]   [Full Text] [Related]  

  • 30. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biology of endometrial cancer].
    Fujita M
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():264-8. PubMed ID: 15535248
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of PTEN in the progression and survival of prostate cancer.
    Deocampo ND; Huang H; Tindall DJ
    Minerva Endocrinol; 2003 Jun; 28(2):145-53. PubMed ID: 12717346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.
    Lin HK; Hu YC; Lee DK; Chang C
    Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness.
    Kotelevets L; van Hengel J; Bruyneel E; Mareel M; van Roy F; Chastre E
    J Cell Biol; 2001 Dec; 155(7):1129-35. PubMed ID: 11756467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibitory effect of tumor suppressor PTEN on cell growth of endometrial carcinoma].
    Wan XY; Shi YF; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):275-8. PubMed ID: 15312361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pten, a protean tumor suppressor.
    Mutter GL
    Am J Pathol; 2001 Jun; 158(6):1895-8. PubMed ID: 11395362
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
    Tsao H; Goel V; Wu H; Yang G; Haluska FG
    J Invest Dermatol; 2004 Feb; 122(2):337-41. PubMed ID: 15009714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway.
    Yuan XJ; Whang YE
    Oncogene; 2002 Jan; 21(2):319-27. PubMed ID: 11803475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
    Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
    Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.